Process variables in inpatient and day clinic psychotherapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032214

Enrollment

516

Registered

2023-08-22

Start date

2024-11-18

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00-F99

Interventions

Group 1: Inpatient or Day Clinic treatment in the Clinic for Psychosomatic Medicine and Psychotherapy During the entire treatmend, participating patients fill out web-based questionnaires on a daily b

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients in the inpatient and day clinic ward of the Clinic for Psychosomatic Medicine and Psychotherapy, LVR-Clinic Düsseldorf

Exclusion criteria

Exclusion criteria: no sufficient knowledge of German

Design outcomes

Primary

Measure	Time frame
Severity of depressive and anxious symptoms (short form PHQ-D) - at time of discharge	—

Secondary

Measure	Time frame
somatic symptom burdon (SSS-8), symptoms of PTSD (PCL-5), eating disorder psychopathology (EDE-8), depersonalization (CDS-2), severity of dependence (SDS), quality of life assessment (WHOQoL), attachment style (ECR-R8), personality function (OPD-SF), interpersonal problems (IIP-32) - at time of discharge valence and arousal as proxy for symptom burdon (SA_Daily: two items generated for the present study) - daily measurement (1x/day) severity of depressive and anxious symptoms (SCL-K11) - weekly measurement (1x/week)	—

Measure

Time frame

somatic symptom burdon (SSS-8), symptoms of PTSD (PCL-5), eating disorder psychopathology (EDE-8), depersonalization (CDS-2), severity of dependence (SDS), quality of life assessment (WHOQoL), attachment style (ECR-R8), personality function (OPD-SF), interpersonal problems (IIP-32) - at time of discharge valence and arousal as proxy for symptom burdon (SA_Daily: two items generated for the present study) - daily measurement (1x/day) severity of depressive and anxious symptoms (SCL-K11) - weekly measurement (1x/week)

—

Countries

Germany

Contacts

Public ContactUlrike Dinger-Ehrenthal

Klinik für Psychosomatische Medizin und Psychotherapie, LVR-Klinikum Düsseldorf

Ulrike.Dinger-Ehrenthal@lvr.de0211 922-4700

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026